Data for: “Loss to follow-up and associated factors in an HIV vaccine preparedness cohort study in Masaka, Uganda”

The study was set up at sites in Tanzania, Mozambique, South Africa, and Uganda to prepare a population of HIV negative individuals at risk of acquiring HIV for possible participation in the PrEPVacc HIV vaccine efficacy trial. In Uganda, the study is conducted at the Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit’s clinical research site in Masaka city, Masaka district.

This dataset only includes information from the Masaka registration cohort collected between July 2018 and March 2021. It contains information on demographic, HIV risk behavioural characteristics and study schedule adherence data/ LTFU data. Participants were considered LTFU if they missed two or more consecutive scheduled study visits and failed to attend further study visits after at least three documented attempts.